Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Update November 18 : NASDAQ 4702 up 0.67%, IBB at 295.25up 2.22% Recent Small Cap picks: CLDX 17.72 off 2.9% with profit taking.Very choppy trade. FCSC 2.67 flat little action, despite Press Release on amputee treatment. Foundation Medicine (FMI) at $25.86 up 2.67%. DNA tests for genetic...
Rayno Life Science: Biotech Stocks Hit A Wall At New Highs Up 40% YTD
Red Tape Today Means Caution-Take Some Off XBI at $167.83 Off 2% Traders, investors, executives even pension funds are thrilled with biotech investing as the stock group rolls on to new highs this month. What may not be appreciated is the 20% move off the October 16 bottom when gloom and doom...
Rayno Life Science Stocks: Up 30%+ YTD After A Volatile October
Investors Whipsawed By V-Shaped Rally NASDAQ at New Highs 4631 DOW at New Highs 17,390 Investors got what was forecasted-a volatile October that moved from fear to greed in two weeks! The market was buffeted by the Ebola scare, macro analysts decrying easy money from the FED and a potential...
Sierra SnowBlog Oct. 2014: White Is the New Orange
Update 11/5/14 No storms on the horizon for next week in the West, but check out this model for a "polar express" in the East and Midwest also creating a "blocking pattern" for the West: http://wxbrad.com/massive-storm-in-the-pacific-drives-arctic-outbreak-into-the-u-s-next-week/ Massive Storm...
Bio Investor Forum #2: T-Cell Therapies and Cancer Targets
Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology is one of the hottest new areas of biopharmaceutical development and on October 7 BIO presented a Therapeutic Session on "T-Cell Therapies: Best Bets in...